Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.160
-0.030 (-2.52%)
Jul 7, 2025, 4:00 PM - Market closed
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $253.73 million as of July 7, 2025. Its market cap has decreased by -47.16% in one year.
Market Cap
253.73M
Enterprise Value
62.61M
1-Year Change
-47.16%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $253.73M, a decrease of -91.19%. That is a compound annual growth rate of -30.30%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |